Evaluation of the effect of IBsolvMIR® on tissue damage, engraftment and graft-versus host disease

Reference number
Coordinator TIKOMED AB
Funding from Vinnova SEK 500 000
Project duration December 2009 - June 2010
Status Completed

Last updated 25 November 2019

Reference number 2009-03929

Page statistics